Insider Trading

Notable insider buying and selling activity across public companies.

Tracking and analysis of reported insider transactions, including executive and director buying or selling. Insider activity can offer insight into internal confidence, valuation perceptions, and potential inflection points.

Articles

3,621 total articles

Bankwell Financial director increases stake with $28,152 purchase

Bankwell Financial director increases stake with $28,152 purchase

Eric J. Dale, a director at Bankwell Financial Group, Inc. (NASDAQ: BWFG), bought 612 shares on March 6, 2026, at $46.00 per share for a total of $28,152. The transaction leaves Dale with 40,419 shares held directly and 41,908 shares held indirectly through a Deferred Compensation Plan. The purchase comes amid a 57% year-over-year share gain and af…

Expand Energy Interim CEO Acquires $215,000 in Company Stock

Expand Energy Interim CEO Acquires $215,000 in Company Stock

Michael Wichterich, serving as interim president and CEO of Expand Energy Corp (NASDAQ: EXE), bought 2,000 shares of the company's common stock on March 6, 2026, paying between $107.00 and $108.00 per share for a total of $215,000. The transaction, filed on a Form 4 with the SEC, brings his direct holdings to 83,498 shares. The purchase arrives ami…

WisdomTree Director Adds $3,267 in Stock via Dividend Reinvestments

WisdomTree Director Adds $3,267 in Stock via Dividend Reinvestments

Tonia L. Pankopf, a director at WisdomTree, Inc. (NASDAQ: WT), purchased $3,267 of company equity through a dividend reinvestment plan across six transactions between November 20, 2024 and February 25, 2026, according to a Form 4 filing. WisdomTree, an asset manager with a $2.28 billion market capitalization that has paid dividends for 13 consecuti…

Insider Jorey Chernett Buys $91,200 of Airsculpt Technologies Stock

Insider Jorey Chernett Buys $91,200 of Airsculpt Technologies Stock

Jorey Chernett, who holds a 10% ownership stake in Airsculpt Technologies, purchased 45,600 shares of the company's common stock on March 6, 2026, paying a weighted average of $2.00 per share for a total of $91,200, according to a Form 4 filing. After the transactions, Chernett's direct holdings in Airsculpt rose to 6,398,211 shares. The move comes…

Altimmune CEO Purchases $70,790 in Stock Amid Weak Q4 Results

Altimmune CEO Purchases $70,790 in Stock Amid Weak Q4 Results

Altimmune President and CEO Jerome Benedict Durso acquired 20,000 shares of the company on March 6, 2026, paying a weighted average of $3.5395 per share for a total of $70,790. The purchase occurred while the stock traded near $3.54 after a 15% decline over the prior week. The company recently reported fourth-quarter 2025 results that missed expect…

Quantum-Si Director Adds 500,000 Shares in $459,800 Purchase

Quantum-Si Director Adds 500,000 Shares in $459,800 Purchase

Quantum-Si Inc. director Charles R. Kummeth purchased 500,000 shares of Class A Common Stock on March 5, 2026, paying a weighted average of $0.9196 per share for a total outlay of $459,800. The trade leaves Kummeth with 855,000 directly held shares. The company's shares are trading near their 52-week low and recent quarterly results showed mixed ou…

Orthofix CP&BOO Vitale Lucas Sells 2,312 Shares to Cover RSU Taxes

Orthofix CP&BOO Vitale Lucas Sells 2,312 Shares to Cover RSU Taxes

Vitale Lucas, Chief Product and Business Operations Officer at Orthofix Medical Inc. (NASDAQ: OFIX), disposed of 2,312 shares across two transactions on March 4 and March 5, 2026, to satisfy tax obligations tied to restricted stock unit settlements. The trades occurred at weighted average prices of $12.9163 and $12.5508, respectively. Following the…

Veracyte CFO Disposes $662,869 in Shares Under Pre-Arranged Plan

Veracyte CFO Disposes $662,869 in Shares Under Pre-Arranged Plan

Veracyte Inc. Chief Financial Officer Rebecca Chambers sold 18,341 shares on March 4, 2026, for proceeds totaling $662,869. The sales were made under a Rule 10b5-1 plan adopted in August 2025. The transactions occurred as Veracyte reported stronger-than-expected fourth-quarter 2025 results and management reaffirmed 2026 guidance; analysts issued di…